<?xml version="1.0" encoding="UTF-8"?>
<p id="par0230">In addition to potential shock, stage III is also marked by extra-pulmonary involvement, such as vasoplegia, myocarditis, and organ failure. Treatment is essentially based on the use of immunomodulatory therapies in order to improve systemic inflammation and to block consequent organ failure. The use of corticosteroids may be helpful in this phase, generally in tandem with the use of cytokine inhibitors. Intravenous immune globulin (IVIG) may also be considered as an immune system modulator. Rapid application of such a treatment plan can potentially enhance patient prognosis, which is basically poor in this stage [
 <xref rid="bib0040" ref-type="bibr">8</xref>,
 <xref rid="bib0385" ref-type="bibr">77</xref>,
 <xref rid="bib0390" ref-type="bibr">78</xref>].
</p>
